A potential therapeutic approach to overload-induced bone loss around implant: parathyroid hormone (PTH).

[1]  D. Tatakis,et al.  Recombinant human bone morphogenetic protein-2 for peri-implant bone regeneration: a case report. , 2011, Journal of periodontology.

[2]  W. Misiorowski.  Parathyroid hormone and its analogues — molecular mechanisms of action and efficacy in osteoporosis therapy Parathormon i jego analogi — molekularne mechanizmy działania a skuteczność w leczeniu osteoporozy , 2011 .

[3]  J. Bechtold,et al.  Parathyroid Hormone Treatment Increases Fixation of Orthopedic Implants with Gap Healing: A Biomechanical and Histomorphometric Canine Study of Porous Coated Titanium Alloy Implants in Cancellous Bone , 2011, Calcified Tissue International.

[4]  T. Braun,et al.  Teriparatide and osseous regeneration in the oral cavity. , 2010, The New England journal of medicine.

[5]  Á. Oteo-Álvaro,et al.  Atrophic humeral shaft nonunion treated with teriparatide (rh PTH 1-34): a case report. , 2010, Journal of shoulder and elbow surgery.

[6]  B. Gruber,et al.  Successful treatment of sternal fracture nonunion with teriparatide , 2010, Osteoporosis International.

[7]  R. Jung,et al.  Evaluation of parathyroid hormone bound to a synthetic matrix for guided bone regeneration around dental implants: a histomorphometric study in dogs. , 2010, Journal of periodontology.

[8]  S. Bukata,et al.  Teriparatide May Accelerate Healing in Delayed Unions of Type III Odontoid Fractures: A Report of 3 Cases , 2010, Journal of spinal disorders & techniques.

[9]  H. Genant,et al.  Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double‐blind study of 102 postmenopausal women with distal radial fractures , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  R. T. Hart,et al.  Local bone formation due to combined mechanical loading and intermittent hPTH-(1-34) treatment and its correlation to mechanical signal distributions. , 2009, Journal of biomechanics.

[11]  L. Lanyon,et al.  Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice. , 2008, Bone.

[12]  R. Jung,et al.  The effect of matrix bound parathyroid hormone on bone regeneration. , 2007, Clinical oral implants research.

[13]  J. A. Currey,et al.  Effect of mechanical stimuli on skeletal regeneration around implants. , 2007, Bone.

[14]  J. Houck,et al.  Accelerated Fracture Healing , 2006, The Journal of the American Academy of Orthopaedic Surgeons.

[15]  C. Misch,et al.  A positive correlation between occlusal trauma and peri-implant bone loss: literature support. , 2005, Implant dentistry.

[16]  B. Mitlak,et al.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). , 2005, The Journal of bone and joint surgery. American volume.

[17]  B. L. Riggs,et al.  Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  U. Joos,et al.  Treatment of severe peri-implant bone loss using autogenous bone and a bioabsorbable polymer that delivered doxycycline (Atridox). , 2004, The British journal of oral & maxillofacial surgery.

[19]  A. Walmsley,et al.  Management of peri-implant bone loss using guided bone regeneration: a clinical report. , 2004, The Journal of prosthetic dentistry.

[20]  W. Roberts,et al.  Mechanism of osseointegration: characterization of supporting bone with indentation testing and backscattered imaging , 2004 .

[21]  V. Tangpricha,et al.  Prevalence of vitamin D deficiency in patients attending an outpatient cancer care clinic in Boston. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[22]  X. Guo,et al.  Trabecular Bone Response to Mechanical and Parathyroid Hormone Stimulation: The Role of Mechanical Microenvironment , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  J. Finkelstein,et al.  The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.

[24]  Jiliang Li,et al.  Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. , 2003, Endocrinology.

[25]  A. Piattelli,et al.  Clinical and histologic aspects of dental implants removed due to mobility. , 2003, Journal of periodontology.

[26]  A. Díez-Pérez,et al.  The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  A. Vissink,et al.  Microbiota around root-form endosseous implants: a review of the literature. , 2002, The International journal of oral & maxillofacial implants.

[28]  F. Khoury,et al.  Surgical therapy of peri-implant disease: a 3-year follow-up study of cases treated with 3 different techniques of bone regeneration. , 2001, Journal of periodontology.

[29]  M W Bidez,et al.  A bioengineered implant for a predetermined bone cellular response to loading forces. A literature review and case report. , 2001, Journal of periodontology.

[30]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[31]  R. Lindsay,et al.  Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. , 2000, The Journal of clinical endocrinology and metabolism.

[32]  H. Genant,et al.  Bone Mass Continues to Increase at the Hip After Parathyroid Hormone Treatment Is Discontinued in Glucocorticoid‐Induced Osteoporosis: Results of a Randomized Controlled Clinical Trial , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  J. Whitfield,et al.  Design and applications of parathyroid hormone analogues. , 1999, Current medicinal chemistry.

[34]  P. Roberson,et al.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. , 1999, The Journal of clinical investigation.

[35]  D. Burr,et al.  Microdamage adjacent to endosseous implants. , 1999, Bone.

[36]  John B. Brunski,et al.  In Vivo Bone Response to Biomechanical Loading at the Bone/Dental-Implant Interface , 1999, Advances in dental research.

[37]  Wei Wei,et al.  Parathyroid Hormone and Mechanical Usage Have a Synergistic Effect in Rat Tibial Diaphyseal Cortical Bone , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  J. Hirsch,et al.  Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. , 1998, European journal of oral sciences.

[39]  J. Hirsch,et al.  Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. , 1998, European journal of oral sciences.

[40]  A. Piattelli,et al.  Histologic observations on 230 retrieved dental implants: 8 years' experience (1989-1996). , 1998, Journal of periodontology.

[41]  N. Hardt,et al.  Treatment of severe peri-implant bone loss using autogenous bone and a resorbable membrane. Case report and literature review. , 1997, Clinical oral implants research.

[42]  F. Isidor,et al.  Histological evaluation of peri-implant bone at implants subjected to occlusal overload or plaque accumulation. , 1997, Clinical oral implants research.

[43]  F. Isidor,et al.  Loss of osseointegration caused by occlusal load of oral implants. A clinical and radiographic study in monkeys. , 1996, Clinical oral implants research.

[44]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[45]  D van Steenberghe,et al.  A study of 589 consecutive implants supporting complete fixed prostheses. Part II: Prosthetic aspects. , 1992, The Journal of prosthetic dentistry.

[46]  D van Steenberghe,et al.  Fixture design and overload influence marginal bone loss and fixture success in the Brånemark system. , 1992, Clinical oral implants research.

[47]  R. Bumsted,et al.  Case Report and Literature Review , 1980 .

[48]  W. Misiorowski.  [Parathyroid hormone and its analogues - molecular mechanisms of action and efficacy of osteoporosis therapy]. , 2011, Endokrynologia Polska.

[49]  Jane E. Aubin,et al.  Mesenchymal Stem Cells and Osteoblast Differentiation , 2008 .

[50]  J. Jovanović,et al.  BIOMECHANICAL MODEL OF VERTEBRA BASED ON BONE REMODELING , 2004 .

[51]  D B Burr,et al.  Targeted and nontargeted remodeling. , 2002, Bone.

[52]  A. Parfitt.  Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. , 2002, Bone.

[53]  H. Hagino,et al.  Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia , 2001, Journal of Bone and Mineral Metabolism.

[54]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[55]  W. Roberts,et al.  REMODELING DYNAMICS OF BONE SUPPORTING RIGIDLY FIXED TITANIUM IMPLANTS: A HISTOMORPHOMETRIC COMPARISON IN FOUR SPECIES INCLUDING HUMANS , 1995, Implant dentistry.

[56]  L. Mühlbradt,et al.  Mechanoperception of natural teeth versus endosseous implants revealed by magnitude estimation. , 1989, The International journal of oral & maxillofacial implants.

[57]  M. Hultin,et al.  Literature review and case report , 1978 .

[58]  J. Cornish,et al.  Mitogen-Activated Protein Kinase Signaling Pathways Subserve the Mitogenic and Antiapoptotic Actions of , 2022 .